Yipin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yipin Zhao has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Zebin Lin
Department of Geriatrics, Zhongshan Hospital Xiamen University, Xiamen, Fujian, 361000, China
9 shared publicationsXinlong Di
Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
6 shared publicationsJianmin Tang
Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450014, China
5 shared publicationsLi Xiao
Department of General Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
5 shared publicationsYuhao Liu
Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases), Central China Fuwai Hospital of Zhengzhou University, Henan Provincial Cardiovascular Hospital, Zhengzhou, Henan, People’s Republic of China
5 shared publications- Zebin Lin
Department of Geriatrics , Zhongshan Hospital Xiamen University , 201 Hubin South Road, Xiamen , Fujian , China , xmu.edu.cn
5 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-14
Prognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes
Background: Even after successful primary percutaneous coronary intervention (PPCI), a substantial proportion of ST-elevation myocardial infarction (STEMI) patients develop major adverse cardiovascular events (MACE). Neutrophil extracellular trap formation (NETosis) contributes to atherothrombosis and coronary microvascular injury, but the prognostic value of circulating NETosis biomarkers in STEMI has not been systematically compared. Methods: We studied 420 STEMI patients who survived index hospitalisation after PPCI. Plasma citrullinated histone H3 (H3Cit), cell-free DNA (cfDNA) and nucleosomes were measured at admission. The primary endpoint was MACE; all-cause death was secondary. Incremental prognostic value over a conventional model was assessed by ΔC-index, net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Over a median 545-day follow-up, 81 patients (19.3%) experienced MACE and 36 (8.6%) died. In fully adjusted Cox models, each 100ng/mL increase in H3Cit was independently associated with MACE (HR 1.511, 95% CI 1.155– 1.977, P=0.003) and death (HR 1.752, 95% CI 1.203– 2.552, P=0.003). Q4 vs Q1–Q3 H3Cit independently predicted MACE (HR 2.139, P=0.002) and death (HR 2.836, P=0.004). cfDNA was associated with death but not MACE after adjustment; nucleosomes lost significance after full adjustment. Adding H3Cit improved discrimination for MACE (ΔC-index 0.042; NRI 0.417; IDI 0.022) and death (ΔC-index 0.055). The prognostic association of H3Cit was directionally consistent across prespecified subgroups. Conclusion: Among three circulating NET biomarkers, H3Cit provides the strongest and most consistent prognostic information for MACE and death after STEMI and offers meaningful incremental value beyond established clinical risk factors, supporting NETosis as a potentially actionable pathway for post-STEMI risk stratification.
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-14
Open AccessPrognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes
Background: Even after successful primary percutaneous coronary intervention (PPCI), a substantial proportion of ST-elevation myocardial infarction (STEMI) patients develop major adverse cardiovascular events (MACE). Neutrophil extracellular trap formation (NETosis) contributes to atherothrombosis and coronary microvascular injury, but the prognostic value of circulating NETosis biomarkers in STEMI has not been systematically compared. Methods: We studied 420 STEMI patients who survived index hospitalisation after PPCI. Plasma citrullinated histone H3 (H3Cit), cell-free DNA (cfDNA) and nucleosomes were measured at admission. The primary endpoint was MACE; all-cause death was secondary. Incremental prognostic value over a conventional model was assessed by ΔC-index, net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Over a median 545-day follow-up, 81 patients (19.3%) experienced MACE and 36 (8.6%) died. In fully adjusted Cox models, each 100ng/mL increase in H3Cit was independently associated with MACE (HR 1.511, 95% CI 1.155– 1.977, P=0.003) and death (HR 1.752, 95% CI 1.203– 2.552, P=0.003). Q4 vs Q1–Q3 H3Cit independently predicted MACE (HR 2.139, P=0.002) and death (HR 2.836, P=0.004). cfDNA was associated with death but not MACE after adjustment; nucleosomes lost significance after full adjustment. Adding H3Cit improved discrimination for MACE (ΔC-index 0.042; NRI 0.417; IDI 0.022) and death (ΔC-index 0.055). The prognostic association of H3Cit was directionally consistent across prespecified subgroups. Conclusion: Among three circulating NET biomarkers, H3Cit provides the strongest and most consistent prognostic information for MACE and death after STEMI and offers meaningful incremental value beyond established clinical risk factors, supporting NETosis as a potentially actionable pathway for post-STEMI risk stratification.
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-11
C-Reactive Protein-Triglyceride Glucose Index and Mortality in Patients with Ventricular Septal Rupture After Acute Myocardial Infarction
Background: Ventricular septal rupture (VSR) is a life-threatening complication of acute myocardial infarction (AMI). The C-reactive protein-triglyceride glucose index (CTI) integrates insulin resistance (IR) and inflammation. The present study was designed to investigate the correlation between CTI and 1-year all-cause mortality in VSR patients after AMI. Methods: 284 VSR patients were consecutively enrolled at Fuwai Central China Cardiovascular Hospital between January 2018 and April 2025. According to the median CTI value (6.408), the 284 VSR patients were divided into two groups. The relationship between CTI and clinical outcomes was evaluated using multivariate logistic regression analysis, followed by mediation analysis to explore indirect statistical associations. Results: 1-year all-cause mortality in VSR patients was 71.8% (204/284). The mortality of the high CTI group was significantly higher than that of the low CTI group (87.3% vs 56.3%, P < 0.001). Multivariate logistic regression analysis revealed that CTI was associated with mortality (OR = 2.89, 95% CI: 1.85– 4.51, P < 0.001), with mortality showing an upward trend as CTI levels increased (P < 0.001). Mediation analyses identified indirect statistical associations involving neutrophil count and NT-proBNP, with mediation proportions of 65.8% and 35.3%, respectively (both P < 0.05). Conclusion: CTI is associated with mortality but not independently, with indirect statistical associations involving inflammation and increased cardiac load.
- 1 August 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-11
Open AccessC-Reactive Protein-Triglyceride Glucose Index and Mortality in Patients with Ventricular Septal Rupture After Acute Myocardial Infarction
Background: Ventricular septal rupture (VSR) is a life-threatening complication of acute myocardial infarction (AMI). The C-reactive protein-triglyceride glucose index (CTI) integrates insulin resistance (IR) and inflammation. The present study was designed to investigate the correlation between CTI and 1-year all-cause mortality in VSR patients after AMI. Methods: 284 VSR patients were consecutively enrolled at Fuwai Central China Cardiovascular Hospital between January 2018 and April 2025. According to the median CTI value (6.408), the 284 VSR patients were divided into two groups. The relationship between CTI and clinical outcomes was evaluated using multivariate logistic regression analysis, followed by mediation analysis to explore indirect statistical associations. Results: 1-year all-cause mortality in VSR patients was 71.8% (204/284). The mortality of the high CTI group was significantly higher than that of the low CTI group (87.3% vs 56.3%, P < 0.001). Multivariate logistic regression analysis revealed that CTI was associated with mortality (OR = 2.89, 95% CI: 1.85– 4.51, P < 0.001), with mortality showing an upward trend as CTI levels increased (P < 0.001). Mediation analyses identified indirect statistical associations involving neutrophil count and NT-proBNP, with mediation proportions of 65.8% and 35.3%, respectively (both P < 0.05). Conclusion: CTI is associated with mortality but not independently, with indirect statistical associations involving inflammation and increased cardiac load.
- Open Access
- 29 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Association of alkaline phosphatase to platelet ratio index with ICU mortality in patients with cardiac arrest
The present study aimed to investigate the association between the alkaline phosphatase-to-platelet ratio index (APPRI) and intensive care unit (ICU) mortality in patients with cardiac arrest (CA), and further explore its potential value for risk stratification in this specific population. A total of 374 CA patients were included in our analysis. They were divided into the survivor group (n = 180) and non-survivor group (n = 194) based on ICU survival status. Baseline characteristics of the two groups were summarized and compared. Univariate and multivariate logistic regression analyses were conducted to explore the association between the alkaline APPRI and ICU mortality. Receiver operating characteristic (ROC) curve analysis was used to determine APPRI's optimal cutoff value for predicting ICU mortality. The Kaplan-Meier method was applied to estimate survival curves of different groups, with the log-rank test used to compare survival differences. The non-survivor group exhibited higher APPRI values than the survivor group (0.430 [0.296, 0.733] vs.0.358 [0.246, 0.533)], P < 0.001). Univariate logistic regression analysis showed that APPRI (odds ratio (OR) = 1.077, 95% confidence interval (CI): 1.013-1.146, P = 0.018) was associated with ICU mortality. Multivariate logistic regression analysis revealed that APPRI was one of the independent predictors of ICU mortality (OR = 1.110, 95% CI: 1.022-1.205, P = 0.013). The ROC curve determined the APPRI optimal cut-off value for ICU mortality to be 0.576. The Kaplan-Meier curves showed that patients with APPRI > 0.576 had a higher ICU mortality than that of patients with APPRI ≤ 0.576 (log-rank test P = 0.017). APPRI is independently associated with ICU mortality in patients with CA, and the index effectively stratifies CA patients at risk of ICU deat.
- 29 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessAssociation of alkaline phosphatase to platelet ratio index with ICU mortality in patients with cardiac arrest
The present study aimed to investigate the association between the alkaline phosphatase-to-platelet ratio index (APPRI) and intensive care unit (ICU) mortality in patients with cardiac arrest (CA), and further explore its potential value for risk stratification in this specific population. A total of 374 CA patients were included in our analysis. They were divided into the survivor group (n = 180) and non-survivor group (n = 194) based on ICU survival status. Baseline characteristics of the two groups were summarized and compared. Univariate and multivariate logistic regression analyses were conducted to explore the association between the alkaline APPRI and ICU mortality. Receiver operating characteristic (ROC) curve analysis was used to determine APPRI's optimal cutoff value for predicting ICU mortality. The Kaplan-Meier method was applied to estimate survival curves of different groups, with the log-rank test used to compare survival differences. The non-survivor group exhibited higher APPRI values than the survivor group (0.430 [0.296, 0.733] vs.0.358 [0.246, 0.533)], P < 0.001). Univariate logistic regression analysis showed that APPRI (odds ratio (OR) = 1.077, 95% confidence interval (CI): 1.013-1.146, P = 0.018) was associated with ICU mortality. Multivariate logistic regression analysis revealed that APPRI was one of the independent predictors of ICU mortality (OR = 1.110, 95% CI: 1.022-1.205, P = 0.013). The ROC curve determined the APPRI optimal cut-off value for ICU mortality to be 0.576. The Kaplan-Meier curves showed that patients with APPRI > 0.576 had a higher ICU mortality than that of patients with APPRI ≤ 0.576 (log-rank test P = 0.017). APPRI is independently associated with ICU mortality in patients with CA, and the index effectively stratifies CA patients at risk of ICU deat.
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 5407966
Pan‐Immune‐Inflammation Value: Related to Perforation Diameter and Pulmonary Artery Pressure in Ventricular Septal Rupture Patients
Objective: This study investigated the relationship between the pan‐immune‐inflammation value (PIV) and the perforation diameter in patients with ventricular septal rupture (VSR), as well as the changes in pulmonary artery systolic pressure ( Δ PASP) after transcatheter closure. Methods: The clinical data from 133 VSR patients who underwent transcatheter closure were analyzed. Patients were divided into high and low PIV groups based on a median cutoff value of 6. Boruta was used for exploratory variable screening; prespecified covariate sets were used for adjusted models. A generalized additive model (GAM) was used to explore the potential nonlinear relationships. Where a nonlinear association was suggested by the GAM, a piecewise linear regression model was subsequently fitted to precisely quantify the threshold effects and the differential associations of PIV/100 with Δ PASP and perforation diameter on either side of the identified inflection point. Results: One hundred thirty‐three patients with VSR (mean age 67 years, 50.6% female) were enrolled. Linear regression showed no statistically significant association between PIV/100 and Δ PASP. GAM suggested a possible nonlinear pattern between PIV/100 and Δ PASP (and perforation diameter). In piecewise models, an inverse association was observed above the break point, but this pattern was attenuated after multivariable adjustment and in sensitivity analyses. In discrimination analyses, adding PIV/100 to the baseline model yielded a modest numerical increase in AUC, but the incremental gain was not statistically significant. Conclusion: PIV may serve as an adjunct inflammatory marker in VSR patients undergoing transcatheter closure; however, the break point findings are exploratory and the incremental predictive value warrants validation in larger, independent cohorts with better adjudication of infection/systemic inflammation.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 5407966
Open AccessPan‐Immune‐Inflammation Value: Related to Perforation Diameter and Pulmonary Artery Pressure in Ventricular Septal Rupture Patients
Objective: This study investigated the relationship between the pan‐immune‐inflammation value (PIV) and the perforation diameter in patients with ventricular septal rupture (VSR), as well as the changes in pulmonary artery systolic pressure ( Δ PASP) after transcatheter closure. Methods: The clinical data from 133 VSR patients who underwent transcatheter closure were analyzed. Patients were divided into high and low PIV groups based on a median cutoff value of 6. Boruta was used for exploratory variable screening; prespecified covariate sets were used for adjusted models. A generalized additive model (GAM) was used to explore the potential nonlinear relationships. Where a nonlinear association was suggested by the GAM, a piecewise linear regression model was subsequently fitted to precisely quantify the threshold effects and the differential associations of PIV/100 with Δ PASP and perforation diameter on either side of the identified inflection point. Results: One hundred thirty‐three patients with VSR (mean age 67 years, 50.6% female) were enrolled. Linear regression showed no statistically significant association between PIV/100 and Δ PASP. GAM suggested a possible nonlinear pattern between PIV/100 and Δ PASP (and perforation diameter). In piecewise models, an inverse association was observed above the break point, but this pattern was attenuated after multivariable adjustment and in sensitivity analyses. In discrimination analyses, adding PIV/100 to the baseline model yielded a modest numerical increase in AUC, but the incremental gain was not statistically significant. Conclusion: PIV may serve as an adjunct inflammatory marker in VSR patients undergoing transcatheter closure; however, the break point findings are exploratory and the incremental predictive value warrants validation in larger, independent cohorts with better adjudication of infection/systemic inflammation.
- Open Access
- 5 November 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-13
Association of hemoglobin glycation index with frailty and all-cause mortality in hypertensive patients
Hypertensive patients are prone to frailty, but the exact link between them remains unclear. This study aims to evaluate the HbA1c glycated index (HGI) as a biomarker for frailty and mortality in hypertensive patients. 1773 hypertensive participants were included in the CHARLS database. HGI was calculated as measured HbA1c minus predicted HbA1c. Associations with frailty and mortality were evaluated via multivariable logistic regression, Cox regression, mediation analysis, and threshold detection. HGI was independently associated with frailty (adjusted OR = 1.28, 95% CI:1.03–1.60), with diabetes mediating 27.8% of this association. It also showed a U-shaped relationship with all-cause mortality (inflection point: HGI=-0.15). In the overall hypertensive population, when HGI ≥ -0.15, there is no significant association between HGI and mortality risk (adjusted HR = 1.17, 95% CI: 0.92–1.50). But in the frailty subgroup with HGI ≥-0.15, per 1-unit HGI increase 60% higher mortality risk (HR = 1.60, 95% CI:1.11–2.32). For HGI <-0.15, higher HGI was linked to lower mortality (adjusted HR = 0.68, 95% CI:0.49–0.95), with a similar trend in the frailty subgroup (adjusted HR = 0.36, 95% CI:0.13–0.97). This study demonstrates that the HGI serves as a biomarker for both frailty and mortality in hypertensive patients. Elevated HGI is associated with increased frailty risk, while its U-shaped relationship with all-cause mortality highlights critical implications for risk stratification.
- 5 November 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-13
Open AccessAssociation of hemoglobin glycation index with frailty and all-cause mortality in hypertensive patients
Hypertensive patients are prone to frailty, but the exact link between them remains unclear. This study aims to evaluate the HbA1c glycated index (HGI) as a biomarker for frailty and mortality in hypertensive patients. 1773 hypertensive participants were included in the CHARLS database. HGI was calculated as measured HbA1c minus predicted HbA1c. Associations with frailty and mortality were evaluated via multivariable logistic regression, Cox regression, mediation analysis, and threshold detection. HGI was independently associated with frailty (adjusted OR = 1.28, 95% CI:1.03–1.60), with diabetes mediating 27.8% of this association. It also showed a U-shaped relationship with all-cause mortality (inflection point: HGI=-0.15). In the overall hypertensive population, when HGI ≥ -0.15, there is no significant association between HGI and mortality risk (adjusted HR = 1.17, 95% CI: 0.92–1.50). But in the frailty subgroup with HGI ≥-0.15, per 1-unit HGI increase 60% higher mortality risk (HR = 1.60, 95% CI:1.11–2.32). For HGI <-0.15, higher HGI was linked to lower mortality (adjusted HR = 0.68, 95% CI:0.49–0.95), with a similar trend in the frailty subgroup (adjusted HR = 0.36, 95% CI:0.13–0.97). This study demonstrates that the HGI serves as a biomarker for both frailty and mortality in hypertensive patients. Elevated HGI is associated with increased frailty risk, while its U-shaped relationship with all-cause mortality highlights critical implications for risk stratification.
- Open Access
- 25 July 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
The ABIC score for assessing long-term outcomes in elderly hospitalized patients with acute exacerbations of chronic heart failure
The purpose of this study was to evaluate the predictive value of the ABIC score in the long-term prognosis of elderly patients with acute exacerbations of chronic heart failure (CHF), and to explore whether its integration with other known prognostic variables could enhance the performance of a predictive model. This is a retrospective cohort study of elderly patients with acute exacerbation of CHF who were hospitalized for the first time. The main clinical outcome was all-cause mortality within three years. Cox regression and Lasso regression were used to screen variables. The screened variables, along with the ABIC score, were included in the multivariate Cox regression analysis to construct a predictive nomogram model. A total of 365 patients with acute exacerbation of CHF were included. During the 3-year follow-up period, 87 patients experienced all-cause death, including 53 cardiac deaths. A total of 4 variables [NT-proBNP, serum urea nitrogen (BUN), red cell distribution width-coefficient of variation (RDW-CV) and prealbumin] were screened by univariate Cox regression analysis and Lasso regression analysis. The multivariate COX regression results showed that the risk of death increased by 33% with the increase of ABIC score by 1 point. The results of ROC curve analysis show that the area under the curve (AUC) of the ABIC score is 0.685, while the AUC of the Nomograph including the ABIC score is 0.840. The ABIC score is associated with long-term adverse outcomes in elderly hospitalized patients with acute exacerbation of CHF. The integration with established prognostic variables (NT-proBNP, BUN, RDW-CV, prealbumin) significantly improves model performance, highlighting the combined value of multiple organ dysfunction and cardiac biomarkers in risk stratification.
- 25 July 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Open AccessThe ABIC score for assessing long-term outcomes in elderly hospitalized patients with acute exacerbations of chronic heart failure
The purpose of this study was to evaluate the predictive value of the ABIC score in the long-term prognosis of elderly patients with acute exacerbations of chronic heart failure (CHF), and to explore whether its integration with other known prognostic variables could enhance the performance of a predictive model. This is a retrospective cohort study of elderly patients with acute exacerbation of CHF who were hospitalized for the first time. The main clinical outcome was all-cause mortality within three years. Cox regression and Lasso regression were used to screen variables. The screened variables, along with the ABIC score, were included in the multivariate Cox regression analysis to construct a predictive nomogram model. A total of 365 patients with acute exacerbation of CHF were included. During the 3-year follow-up period, 87 patients experienced all-cause death, including 53 cardiac deaths. A total of 4 variables [NT-proBNP, serum urea nitrogen (BUN), red cell distribution width-coefficient of variation (RDW-CV) and prealbumin] were screened by univariate Cox regression analysis and Lasso regression analysis. The multivariate COX regression results showed that the risk of death increased by 33% with the increase of ABIC score by 1 point. The results of ROC curve analysis show that the area under the curve (AUC) of the ABIC score is 0.685, while the AUC of the Nomograph including the ABIC score is 0.840. The ABIC score is associated with long-term adverse outcomes in elderly hospitalized patients with acute exacerbation of CHF. The integration with established prognostic variables (NT-proBNP, BUN, RDW-CV, prealbumin) significantly improves model performance, highlighting the combined value of multiple organ dysfunction and cardiac biomarkers in risk stratification.
- Open Access
- 26 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-13
Association between heavy metal exposure and heart failure incidence and mortality: insights from NHANES data (2003–2018)
Environmental heavy metal exposure is a potential yet understudied risk factor for heart failure (HF), a global health burden with rising prevalence. While toxic metals like cadmium (Cd), mercury (Hg), and arsenic (As) are linked to cardiovascular diseases, their roles in HF incidence and prognosis remain unclear. The associations between heavy metals and HF outcomes were analyzed using NHANES 2003–2018 data (n = 11,592). Metals were measured in blood (Cd, Hg, Pb) and urine (As, Hg, others) using inductively coupled plasma mass spectrometry (ICP-MS). Confounding factors were addressed through propensity score matching (PSM). HF incidence was evaluated using logistic regression, while mortality was assessed via Cox regression. Mechanistic pathways were explored through causal mediation analysis. After PSM (n = 987, 337 HF cases), blood Cd showed a positive association with HF incidence (OR:1.35, 95%CI:1.05–1.72), while urinary Hg (OR:0.78, 95%CI:0.63–0.98) and As (OR:0.84, 95%CI:0.72–0.99) exhibited protective effects. Urinary As correlated with elevated cardiovascular mortality in HF patients (HR:1.19, 95%CI:1.04–1.35). Mediation analysis indicated Cd’s effect on HF was mediated via CHD/OMI, whereas Hg’s protection involved reduced CHD/OMI incidence. As directly lowered HF risk without mediation. These findings underscore cadmium’s role as a risk factor and the paradoxical effects of mercury and arsenic: low to moderate concentrations of Hg/As may reduce HF risk through indirect pathways (e.g., reduced CHD/OMI for Hg) or direct cardioprotective mechanisms (for As), yet arsenic’s association with mortality highlights its long-term cardiovascular toxicity. Findings advocate for preventive strategies targeting metal exposure and further research integrating cumulative biomarkers.
- 26 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-13
Open AccessAssociation between heavy metal exposure and heart failure incidence and mortality: insights from NHANES data (2003–2018)
Environmental heavy metal exposure is a potential yet understudied risk factor for heart failure (HF), a global health burden with rising prevalence. While toxic metals like cadmium (Cd), mercury (Hg), and arsenic (As) are linked to cardiovascular diseases, their roles in HF incidence and prognosis remain unclear. The associations between heavy metals and HF outcomes were analyzed using NHANES 2003–2018 data (n = 11,592). Metals were measured in blood (Cd, Hg, Pb) and urine (As, Hg, others) using inductively coupled plasma mass spectrometry (ICP-MS). Confounding factors were addressed through propensity score matching (PSM). HF incidence was evaluated using logistic regression, while mortality was assessed via Cox regression. Mechanistic pathways were explored through causal mediation analysis. After PSM (n = 987, 337 HF cases), blood Cd showed a positive association with HF incidence (OR:1.35, 95%CI:1.05–1.72), while urinary Hg (OR:0.78, 95%CI:0.63–0.98) and As (OR:0.84, 95%CI:0.72–0.99) exhibited protective effects. Urinary As correlated with elevated cardiovascular mortality in HF patients (HR:1.19, 95%CI:1.04–1.35). Mediation analysis indicated Cd’s effect on HF was mediated via CHD/OMI, whereas Hg’s protection involved reduced CHD/OMI incidence. As directly lowered HF risk without mediation. These findings underscore cadmium’s role as a risk factor and the paradoxical effects of mercury and arsenic: low to moderate concentrations of Hg/As may reduce HF risk through indirect pathways (e.g., reduced CHD/OMI for Hg) or direct cardioprotective mechanisms (for As), yet arsenic’s association with mortality highlights its long-term cardiovascular toxicity. Findings advocate for preventive strategies targeting metal exposure and further research integrating cumulative biomarkers.
- Open Access
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 6641-6652
Correlation Between Systemic Immune Inflammation Index(Sll) and Outcome After Occlusion in Patients with Post-Infarction Ventricular Septal Rupture
Background: The Systemic Immune-Inflammation Index (SII) is a key indicator for assessing inflammatory status. This study aims to determine the association between SII and prognosis following occlusion in patients with post-infarction ventricular septal rupture (PIVSR). Methods: A total of 130 patients admitted to Fuwai Central China Cardiovascular Hospital between 2018 and 2023 were included in this retrospective study. Based on the tertiles of the Systemic Inflammatory Index (SII), the patients were categorized into two groups: 65 patients in the low SII group and 65 in the high SII group. Variable screening was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) analysis. We conducted multivariable logistic regression analyses to rigorously assess the independent association between SII and short-term outcomes in PIVSR patients. After variable selection, a nomogram was constructed using R, and Restricted Cubic Splines (RCS) were employed to flexibly model nonlinear relationships. Subsequently, the predictive abilities of the screened variables and SII for the outcome were independently evaluated using Receiver Operating Characteristic (ROC) curve analysis. Results: A nomogram model incorporating ALT, UREA, NT-proBNP, and SII was developed to predict the short-term prognosis of PIVSR patients following occlusion surgery. ROC curve analysis demonstrated that the area under the curve (AUC) for SII level was 0.702 (95% CI: 0.599– 0.804, P < 0.001). Incorporating the Systemic Immune-Inflammation Index (SII) significantly improved prognostic accuracy, with Model 2 demonstrating superior discriminatory power (AUC 0.845 vs 0.828) over Model 1. Conclusion: The Systemic Immune-Inflammation (SII) is a convenient and effective prognostic indicator, and the model incorporating SII can facilitate personalized prognostic assessment for patients with post-infarction ventricular septal rupture (PIVSR).
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 6641-6652
Open AccessCorrelation Between Systemic Immune Inflammation Index(Sll) and Outcome After Occlusion in Patients with Post-Infarction Ventricular Septal Rupture
Background: The Systemic Immune-Inflammation Index (SII) is a key indicator for assessing inflammatory status. This study aims to determine the association between SII and prognosis following occlusion in patients with post-infarction ventricular septal rupture (PIVSR). Methods: A total of 130 patients admitted to Fuwai Central China Cardiovascular Hospital between 2018 and 2023 were included in this retrospective study. Based on the tertiles of the Systemic Inflammatory Index (SII), the patients were categorized into two groups: 65 patients in the low SII group and 65 in the high SII group. Variable screening was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) analysis. We conducted multivariable logistic regression analyses to rigorously assess the independent association between SII and short-term outcomes in PIVSR patients. After variable selection, a nomogram was constructed using R, and Restricted Cubic Splines (RCS) were employed to flexibly model nonlinear relationships. Subsequently, the predictive abilities of the screened variables and SII for the outcome were independently evaluated using Receiver Operating Characteristic (ROC) curve analysis. Results: A nomogram model incorporating ALT, UREA, NT-proBNP, and SII was developed to predict the short-term prognosis of PIVSR patients following occlusion surgery. ROC curve analysis demonstrated that the area under the curve (AUC) for SII level was 0.702 (95% CI: 0.599– 0.804, P < 0.001). Incorporating the Systemic Immune-Inflammation Index (SII) significantly improved prognostic accuracy, with Model 2 demonstrating superior discriminatory power (AUC 0.845 vs 0.828) over Model 1. Conclusion: The Systemic Immune-Inflammation (SII) is a convenient and effective prognostic indicator, and the model incorporating SII can facilitate personalized prognostic assessment for patients with post-infarction ventricular septal rupture (PIVSR).
- Open Access
- 17 March 2023
- Published by Springer Nature in Research Square
The ABIC score for Assessing Long-term Outcomes in Elderly Hospitalized Patients with Acute Exacerbations of Chronic Heart Failure
Objectives: Age-bilirubin-international normalized ratio -creatinine (ABIC) score was originally proposed as a tool to assess alcoholic hepatitis survival and to identify patients who respond to corticosteroid treatment. Since the components of this score are associated with prognosis in patients with heart failure, the purpose of this study was to determine the relationship between ABIC score and long-term prognosis of elderly patients with acute exacerbation of chronic heart failure. Methods: This is a retrospective cohort study of elderly patients with acute exacerbation of chronic heart failure who were hospitalized for the first time in the Second Affiliated Hospital of Chongqing Medical University from February 2017 to December 2017. The main clinical outcome was all-cause mortality within three years. Cox regression and Lasso regression were used to screen variables and build a prognostic model. Combined with the ABIC score, the final model was adjusted, and the predictive ability of the model was evaluated. The screened variables with ABIC score were incorporated into the multivariate Cox regression analysis and a nomogram prediction model was built. The receiver operating characteristic curve and calibration curve were used to evaluate the predictive ability and accuracy of the model, respectively. Results: A total of 365 patients with acute exacerbation of chronic heart failure were included (median age 78 years, 50.7% female). During the 3-year follow-up period, 87 patients experienced all-cause death, including 53 cardiac deaths. A total of 4 variables (NT-proBNP, BUN, RDW-CV and prealbumin) were screened by univariate Cox regression analysis and Lasso regression analysis. The multivariate COX regression results showed that the risk of death increased by 33% with the increase of ABIC score by 1 point (after correcting NT-proBNP, BUN, RDW-CV and prealbumin). The results of ROC curve analysis show that the area under the curve (AUC) of the ABIC score is 0.685, while the AUC of the Nomograph including the ABIC score is 0.840. Conclusions: The ABIC score is associated with long-term adverse outcomes in elderly hospitalized patients with chronic heart failure exacerbations. But its predictive ability for adverse events needs further exploration.
- 17 March 2023
- Published by Springer Nature in Research Square
Open AccessThe ABIC score for Assessing Long-term Outcomes in Elderly Hospitalized Patients with Acute Exacerbations of Chronic Heart Failure
Objectives: Age-bilirubin-international normalized ratio -creatinine (ABIC) score was originally proposed as a tool to assess alcoholic hepatitis survival and to identify patients who respond to corticosteroid treatment. Since the components of this score are associated with prognosis in patients with heart failure, the purpose of this study was to determine the relationship between ABIC score and long-term prognosis of elderly patients with acute exacerbation of chronic heart failure. Methods: This is a retrospective cohort study of elderly patients with acute exacerbation of chronic heart failure who were hospitalized for the first time in the Second Affiliated Hospital of Chongqing Medical University from February 2017 to December 2017. The main clinical outcome was all-cause mortality within three years. Cox regression and Lasso regression were used to screen variables and build a prognostic model. Combined with the ABIC score, the final model was adjusted, and the predictive ability of the model was evaluated. The screened variables with ABIC score were incorporated into the multivariate Cox regression analysis and a nomogram prediction model was built. The receiver operating characteristic curve and calibration curve were used to evaluate the predictive ability and accuracy of the model, respectively. Results: A total of 365 patients with acute exacerbation of chronic heart failure were included (median age 78 years, 50.7% female). During the 3-year follow-up period, 87 patients experienced all-cause death, including 53 cardiac deaths. A total of 4 variables (NT-proBNP, BUN, RDW-CV and prealbumin) were screened by univariate Cox regression analysis and Lasso regression analysis. The multivariate COX regression results showed that the risk of death increased by 33% with the increase of ABIC score by 1 point (after correcting NT-proBNP, BUN, RDW-CV and prealbumin). The results of ROC curve analysis show that the area under the curve (AUC) of the ABIC score is 0.685, while the AUC of the Nomograph including the ABIC score is 0.840. Conclusions: The ABIC score is associated with long-term adverse outcomes in elderly hospitalized patients with chronic heart failure exacerbations. But its predictive ability for adverse events needs further exploration.